A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers
Clinical trial NCT01248052 · COMPLETED
Trial details
- NCT number
- NCT01248052
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-05-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.